{
    "name": "neomycin/polymyxin B/gramicidin ophthalmic",
    "comment": "Rx",
    "other_names": [
        "Gramicidin",
        "Neosporin Ophthalmic Solution",
        "Neocin-PG"
    ],
    "classes": [
        "Antibiotics",
        "Ophthalmic Combos"
    ],
    "source": "https://reference.medscape.com/drug/gramicidin-neomycin-polymyxin-b-gramicidin-ophthalmic-343578",
    "pregnancy": {
        "common": [
            "Animal reproduction studies have not been conducted with neomycin sulfate, polymyxin B sulfate, or bacitracin; not known whether therapy can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity; treatment should be given to a pregnant woman only if clearly needed"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Not known whether drug is excreted in human milk; because many drugs are excreted in human milk, exercise caution when drug is administered to a nursing woman"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Aminglycoside/neomycin hypersensitivity; hypersensitivity to any product component"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Watch for NEOMYCIN ocular sensitivity",
                "Defects in visual acuity may occur with prolonged use",
                "Posterior subpapular cataract formation, and secondary ocular infections reported with prolonged use",
                "Prolonged use may result in overgrowth of nonsusceptible organisms including fungi; if superinfection occurs, appropriate measures should be initiated",
                "Bacterial resistance to may develop; if purulent discharge, inflammation, or pain becomes aggravated, patient should discontinue use and consult a physician",
                "Allergic cross-reactions may occur which could prevent use of any or all of the following antibiotics for treatment of future infections: kanamycin, paromomycin, streptomycin, and possibly gentamicin"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Hypersensitivity",
            "percent": null
        },
        {
            "name": "Itching",
            "percent": null
        },
        {
            "name": "swelling",
            "percent": null
        },
        {
            "name": "and conjunctival erythema",
            "percent": null
        },
        {
            "name": "Local transient irritation",
            "percent": null
        },
        {
            "name": "Vesicular and maculopapular dermatitis",
            "percent": null
        },
        {
            "name": "Angioneurotic edema",
            "percent": null
        },
        {
            "name": "Urticaria",
            "percent": null
        }
    ]
}